A subsidiary of
Dr. Reddy's Laboratories Ltd.

Analytical development

OctoPlus offers analytical solutions – method development & validation - for all challenges related to complex formulations

For every drug product, our experienced analytical teams design, develop and validate the required analytical methods for complex formulations such as:

  • Nanosuspensions
  • Liposomes
  • Microspheres


To make sure that the drug product is continuously monitored, our analytical teams are involved from the start of each project. The team consists of experts with different expertise and knowledge as OctoPlus believes in multidisciplinary research approach to solve complex challenges. Our multidisciplinary group of analytical experts has all tools required to characterize even the most complex formulations.

Our analytical experts are fully equipped with state-of-the-art equipment, are following the Quality by Design principles and uses advanced statistical tools such as Design of Experiments (DoE) and Robustness by Design (RbD) to develop high quality analytical methods in a timely and cost-effective way.

Contact us if you are interested in partnering up  with us!                          





OctoPlus offers analytical solutions for complex challenges

Low concentrations of highly potent compounds?

Interfering excipients or degradation products of controlled release polymers?

We have seen them all over the years

Vision & Mission

Our vision is, either independently or in collaboration, joining forces with the academic world and industry, to make innovative injectables available to a global market. Good health can't wait.


Our mission is to accelerate access to affordable and innovative injectables

Contact us

New website per May 2015

We proudly present our new website which will inform you about our new strategy. Instead of solely offering our services to customers, OctoPlus more and more focuses on strong partnerships and cooperations with academic institutions and industry.


With over 20 years of...

More news

Download Press Release as PDF